As stem cells studies advance, stem cell therapy is looked upon as the go-to treatment option for a number of medical conditions. In a breakthrough development in stem cell studies, researchers at Massachusetts Institute of Technology (MIT) have developed a new programming technique that will allow the production of different types of tissues on-demand on a chip. Treatments for autoimmune diseases such as rheumatoid arthritis and growing tissues on-demand for organ replacement is not a faraway reality.
The global stem cells market is divided on the basis of product, application, technology, and
geography in this report. The research report provides historical and forecast analysis of market size, growth trends, and vital established and emerging growth areas in the global stem cells market. The report serves as a valuable guide for understanding the developments in the global stem cells market during the forecast period. Research data has been collated and presented in a crisp format.
Using graphs and illustrations, the market study presents the current competitive landscape of the global stem cells market with changes in market hierarchy expected during the forecast period. The major companies that are involved in the business of stem cells are mentioned and are profiled for their key attributes.
Request a Sample copy of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132
Overview of Global Stem Cells Market
The global stem cells market was valued at US$26.23 bn in 2013. Consistent research studies around the world to discover the potential of stem cells for the treatment of several medical conditions will lead the market to rise at a 24.2% CAGR from 2012 to 2018. Owing to this, the global stem cells market will be valued at US$119.52 bn by the end of 2018.
Some of the factors that are driving the global stem cells market are: a growing number of stem cell banks, government support for clinical research and stem cell therapy advancements boosting medical tourism for recuperative purposes, and unmet medical needs.
Stem cells are undifferentiated cells that have the remarkable potential to differentiate into several cell types during the early period of growth. These cells can differentiate, either to function as a stem cell or to develop into another cell type with a more specialized function, such as a red blood cell, brain cell, or muscle cell.
By product type, adult, induced pluripotent, very small embryonic-like, human embryonic, and rat neural stem cells are the segments of this market. Of these, adult stem cells account for the largest market share due to a relatively easier procedure to harvest these cells and higher chances of acceptance by the body. Umbilical cord, neuronal, hematopoietic, dental, and mesenchymal are the sub-segments of the adult stem cells segment. Culture, in-vitro fertilization, expansion and sub-culture, isolation, and cryopreservation are the segments that divide the market on the basis of technology. Application-wise, neurology, oncology, cardiovascular, wound care, diabetes, incontinence, orthopedics, hematology, myocardial infarction, spinal cord injuries, liver disorders, and others are the segments of the global stem cells market.
Regional Analysis: http://www.tmrblog.com/2015/12/stem-cells-market.html
North America is a significant market for stem cells accounting for more than 25% of the global market in 2011.
Major Companies in Global Stem Cells Market
STEMCELL Technologies Inc., Biotime Inc., Cellular Engineering Technologies, Celgene Corporation Inc., Brainstorm Cell Therapeutics, Bioheart, Osiris Therapeutics, Cytori Therapeutics Inc., Cellartis AB, California Stem Cells Inc., Angel Biotechnology, and Advanced Cell
No comments:
Post a Comment
Did you like blog? Share your thoughts -